A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

NCT06336928 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2026-03-12

No results posted yet for this study

Summary

This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.

Conditions

  • Breast Carcinoma

Interventions

OTHER

Non-Interventional Study

Non-interventional study

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Southern California

    lead OTHER

Principal Investigators

  • Anastasia Martynova, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-07
Primary Completion
2029-06-07
Completion
2030-06-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06336928 on ClinicalTrials.gov